The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Open accessAbstract
Primary hyperoxaluria (PH) is a rare autosomal recessive disease characterized by oxalate accumulation in the kidneys and other organs. Three loci have been identified: AGXT (PH1), GRHPR (PH2), and HOGA1 (PH3). Here, we compared genotype to phenotype in 355 patients in the Rare Kidney Stone Consortium PH registry and calculated prevalence using publicly available whole-exome data. PH1 (68.4% of families) was the most severe PH type, whereas PH3 (11.0% of families) showed the slowest decline in renal function but the earliest symptoms. A group of patients with disease progression similar to that of PH3, but for whom no mutation was detected (11.3% of families), suggested further genetic heterogeneity. We confirmed that the AGXT p.G170R mistargeting allele resulted in a milder PH1 phenotype; however, other potential AGXT mistargeting alleles caused more severe (fully penetrant) disease. We identified the first PH3 patient with ESRD; a homozygote for two linked, novel missense mutations. Population analysis suggested that PH is an order of magnitude more common than determined from clinical cohorts (prevalence, approximately 1:58,000; carrier frequency, approximately 1:70). We estimated PH to be approximately three times less prevalent among African Americans than among European Americans because of a limited number of common European origin alleles. PH3 was predicted to be as prevalent as PH1 and twice as common as PH2, indicating that PH3 (and PH2) cases are underdiagnosed and/or incompletely penetrant. These results highlight a role for molecular analyses in PH diagnostics and prognostics and suggest that wider analysis of the idiopathic stone-forming population may be beneficial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochat, P., & Rumsby, G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1301564 · Cited by 586
Hoppe, B., Beck, B. B., & Milliner, D. S. (2009) · Kidney International · doi:10.1038/ki.2009.32 · Cited by 375
Self-citationPeroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I
Danpure, C. J., & Jennings, P. R. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80563-4 · Cited by 352
An update on primary hyperoxaluria
Hoppe, B. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.113 · Cited by 312
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Belostotsky, R., Seboun, E., Idelson, G. H., Milliner, D. S., Becker-Cohen, R., Rinat, C., Monico, C. G., Feinstein, S., Ben-Shalom, E., Magen, D., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.023 · Cited by 233
Self-citationPrimary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene
Williams, E. L., Acquaviva, C., Amoroso, A., Chevalier, F., Coulter-Mackie, M., Monico, C. G., Giachino, D., Owen, T., Robbiano, A., Salido, E., et al. (2009) · Human Mutation · doi:10.1002/humu.21021 · Cited by 175
Danpure, C. J., Cooper, P. J., Wise, P. J., & Jennings, P. R. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.4.1345 · Cited by 163
Harambat, J., Fargue, S., Acquaviva, C., Gagnadoux, M.-F., Janssen, F., Liutkus, A., Mourani, C., Macher, M.-A., Abramowicz, D., Legendre, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.435 · Cited by 158
Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy
Harambat, J., van Stralen, K. J., Espinosa, L., Groothoff, J. W., Hulton, S., Čerkauskienė, R., Schaefer, F. S., Verrina, E. E., Jager, K. J., & Cochat, P. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07430711 · Cited by 154
International Registry for Primary Hyperoxaluria
Lieske, J. C., Monico, C. G., Holmes, W. S., Bergstralh, E. J., Slezak, J. M., Rohlinger, A. L., Olson, J. B., & Milliner, D. S. (2005) · American Journal of Nephrology · doi:10.1159/000086360 · Cited by 150
Self-citation
Cited by
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Garrelfs, S. F., Frishberg, Y., Hulton, S. A., Koren, M. J., O’Riordan, W. D., Cochat, P., Deschênes, G., Shasha-Lavsky, H., Saland, J. M., van’t Hoff, W. G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021712 · Cited by 531
Self-citationGalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases
Qin, Z.-X., Zuo, L., Zeng, Z., Ma, R., Xie, W., Zhu, X., & Zhou, X. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2466767 · Cited by 32
Wang, X., Danese, D., Brown, T., Baldwin, J., Sajeev, G., Cook, E. E., Wang, Y., Xu, C., Yang, H., & Moritz, M. L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.703305 · Cited by 13
Metadata
- Authors
- Hopp, K., Cogal, A. G., Bergstralh, E. J., Seide, B. M., Olson, J. B., Meek, A. M., Lieske, J. C., Milliner, D. S., & Harris, P. C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-10
- Volume
- 26
- Issue
- 10
- Pages
- 2559-2570
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2109644074
- Cited by
- 267
- References
- 28
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. https://app.cochat.ai/papers/10.1681/asn.2014070698
- The paper
- Hopp, K., Cogal, A. G., Bergstralh, E. J., Seide, B. M., Olson, J. B., Meek, A. M., Lieske, J. C., Milliner, D. S., & Harris, P. C. (2015). Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2014070698
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.